Cellular Changes in Diabetic and Idiopathic Gastroparesis
Madhusudan Grover(Mayo Clinic), Pankaj J. Pasricha(Mayo Clinic in Arizona), William J. Snape(Hospital of the University of Pennsylvania), Linda Anh B. Nguyen(Stanford University), Kenneth L. Koch(Wake Forest University), Thomas C. Smyrk(Mayo Clinic in Arizona), Thomas L. Abell(University of Louisville), Aynur Ünalp–Arida(National Institutes of Health), Linda Lee(Purdue University West Lafayette), Gianrico Farrugia(Mayo Clinic), Matthew S. Lurken(Mayo Clinic), James Tonascia(Johns Hopkins University), Frank A. Hamilton(National Institute of Diabetes and Digestive and Kidney Diseases), Maria Simonetta Faussone‐Pellegrini(University of Florence), Henry P. Parkman(Temple University), Cheryl E. Bernard(Mayo Clinic), William L. Hasler(Mayo Clinic in Arizona)
Cited by 445
Related Papers
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
|Gastroenterology|2016|696
Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies
|New England Journal of Medicine|2000|675
Defining Translational Research: Implications for Training
|Academic Medicine|2010|670